Simpson Biotech is pleased to provide access to its many patents, scientific articles, and technical presentations. SBC holds 34 issued patents with other else 34 pending in Taiwan, Europe, and US, etc. Currently Simpson Biotech moving forward with important international patent applications for therapeutic applications and clinical trials data for Hepasim, Simpson Biotech’s trademark natural product compound isolated from medicinal mycelia. Over the year Simpson Biotech has published many scientific articles on the therapeutic effects of its natural products and fungal mycelia through its renowned scientific collaborators, Professor Hattori from Toyama University in Japan. Simpson Biotech also makes available for download technical presentations on its proprietary protein expression platform known as HERPEPS.